Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
USFDA Observation
|
Slowing Down Stock
1025.0000
-2.90
(
-0.28
%)
NSE
Sep 01, 2025
15:31 PM
Near 52W Low of ₹1010.00
Volume:
1.6M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
28 May 2024
USFDA Observation
1025.00
-0.28%
First Light | Aurobindo Pharma, Century Plyboards
Hold:
Aurobindo Pharma Ltd.
by
BOB Capital Markets Ltd.
Target: 1200
Target
BOB Capital Markets Ltd.
ARBP: Strong quarter; OAI at Eugia-III an overhang. CPBI: In-line quarter; weak near-term outlook
Aurobindo Pharma Ltd. has lost
-34.69%
in the last 1 Year
More from Aurobindo Pharma Ltd.
Recommended
Market closes higher, Ashok Leyland to invest Rs 5,000 crore to develop batteries in India
Trendlyne Marketwatch |
01 Sep 2025, 03:59PM
Five Interesting Stocks Today - August 29, 2025
The Baseline |
29 Aug 2025
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020